LEQEMBI IQLIK Trademark

Trademark Overview

On Monday, March 6, 2023, a trademark application was filed for LEQEMBI IQLIK with the United States Patent and Trademark Office. The USPTO has given the LEQEMBI IQLIK trademark a serial number of 97825738. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, March 11, 2025. This trademark is owned by Eisai R&D Management Co., Ltd.. The LEQEMBI IQLIK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related disorders, cognitive impairment and dementia
leqembi iqlik

General Information

Serial Number97825738
Word MarkLEQEMBI IQLIK
Filing DateMonday, March 6, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related disorders, cognitive impairment and dementia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEisai R&D Management Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 112-8088
JP
Party NameEisai R&D Management Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 112-8088
JP

Trademark Events

Event DateEvent Description
Thursday, March 9, 2023NEW APPLICATION ENTERED
Monday, March 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 5, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 26, 2023ASSIGNED TO LIE
Tuesday, September 26, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, October 30, 2023ASSIGNED TO EXAMINER
Friday, November 10, 2023NON-FINAL ACTION WRITTEN
Friday, November 10, 2023NON-FINAL ACTION E-MAILED
Friday, November 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2024SOU EXTENSION 1 FILED
Tuesday, September 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 11, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 11, 2025SOU EXTENSION 2 FILED
Wednesday, March 12, 2025SOU EXTENSION 2 GRANTED
Wednesday, March 12, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

iqlik leqembi disorders cognitive impairment dementia related disease preparations treatment prevention alzheimer